IDEAYA Biosciences Statistics
Total Valuation
IDYA has a market cap or net worth of $2.16 billion. The enterprise value is $1.19 billion.
Important Dates
The next estimated earnings date is Monday, November 3, 2025, before market open.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IDYA has 87.64 million shares outstanding. The number of shares has increased by 25.85% in one year.
| Current Share Class | 87.64M |
| Shares Outstanding | 87.64M |
| Shares Change (YoY) | +25.85% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 0.90% |
| Owned by Institutions (%) | 107.38% |
| Float | 81.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 308.13 |
| Forward PS | 107.64 |
| PB Ratio | 2.25 |
| P/TBV Ratio | 2.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 170.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.39, with a Debt / Equity ratio of 0.03.
| Current Ratio | 12.39 |
| Quick Ratio | 12.10 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -35.09% and return on invested capital (ROIC) is -25.02%.
| Return on Equity (ROE) | -35.09% |
| Return on Assets (ROA) | -23.84% |
| Return on Invested Capital (ROIC) | -25.02% |
| Return on Capital Employed (ROCE) | -38.97% |
| Revenue Per Employee | $53,435 |
| Profits Per Employee | -$2.53M |
| Employee Count | 131 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.96% in the last 52 weeks. The beta is 0.12, so IDYA's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | -31.96% |
| 50-Day Moving Average | 23.90 |
| 200-Day Moving Average | 21.96 |
| Relative Strength Index (RSI) | 50.16 |
| Average Volume (20 Days) | 1,246,759 |
Short Selling Information
The latest short interest is 10.09 million, so 11.51% of the outstanding shares have been sold short.
| Short Interest | 10.09M |
| Short Previous Month | 9.65M |
| Short % of Shares Out | 11.51% |
| Short % of Float | 12.33% |
| Short Ratio (days to cover) | 11.00 |
Income Statement
In the last 12 months, IDYA had revenue of $7.00 million and -$331.80 million in losses. Loss per share was -$3.79.
| Revenue | 7.00M |
| Gross Profit | -335.45M |
| Operating Income | -384.23M |
| Pretax Income | -153.74M |
| Net Income | -331.80M |
| EBITDA | -381.76M |
| EBIT | -384.23M |
| Loss Per Share | -$3.79 |
Full Income StatementBalance Sheet
The company has $669.74 million in cash and $26.60 million in debt, giving a net cash position of $965.27 million or $11.01 per share.
| Cash & Cash Equivalents | 669.74M |
| Total Debt | 26.60M |
| Net Cash | 965.27M |
| Net Cash Per Share | $11.01 |
| Equity (Book Value) | 959.65M |
| Book Value Per Share | 10.95 |
| Working Capital | 630.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$293.71 million and capital expenditures -$3.55 million, giving a free cash flow of -$297.26 million.
| Operating Cash Flow | -293.71M |
| Capital Expenditures | -3.55M |
| Free Cash Flow | -297.26M |
| FCF Per Share | -$3.39 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -5,488.94% |
| Pretax Margin | -4,740.03% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IDYA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.85% |
| Shareholder Yield | -25.85% |
| Earnings Yield | -15.38% |
| FCF Yield | -13.78% |
Dividend DetailsAnalyst Forecast
The average price target for IDYA is $47.75, which is 93.87% higher than the current price. The consensus rating is "Buy".
| Price Target | $47.75 |
| Price Target Difference | 93.87% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 137.18% |
| EPS Growth Forecast (5Y) | -30.61% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IDYA has an Altman Z-Score of 15.33 and a Piotroski F-Score of 1.
| Altman Z-Score | 15.33 |
| Piotroski F-Score | 1 |
